Creating the Future for Gene and Cell Therapy
Be part of an international, innovative and fun group!
KCT is a research center based in Kuopio, Finland. We provide high-quality basic and translational research. Our highly professional teams and fully equipped laboratories with the latest cutting-edge devices enable us to provide the scientific know-how and modern technologies to develop advanced therapies.
As a working community, we are very proud of our team spirit that permeates our everyday work and off work activities. We are an international group of people who all work together towards a common goal; to create advanced therapies.
We are frequently looking for new employees who share our vision to be part of KCT. If you are interested, don’t hesitate to send us an open application here.
scientists on the search!
We are seeking for two scientists to join two-year fixed term research projects. The first project is focusing on cardiovascular diseases. The second project aims to resolve some of the remaining challenged in viral gene delivery including controlled transgene expression. Electronic application with cover letter, curriculum vitae and salary request should be sent latest 31st January 2020 from here.
We are searching for novel scientific projects on gene and cell therapy. Accepted projects are granted adequate funding, modern research facilities with cutting-edge technology, a professional scientific team and opportunities for collaboration with the University of Eastern Finland, manufacturing via FinVector and clinical trials at Kuopio University Hospital.
Start the application process by contacting us. We will send you further information on the application process and research plan required.
For further information, please contact: email@example.com
"I was dreaming about working in the field of Gene and Cell Therapy since my Bachelor's studies and joining KCT finally made this dream come true. What makes KCT a great place to work is not only cutting-edge research but also insipiring people who conduct it."- Vita Skirdenko, Ukraine